Anti-CGRPs and Botox: Why, When and How? – Andrew Blumenfeld

In his second lecture, Andrew Blumenfeld presented the US treatment guidelines for onabotulinumtoxin A (botox) in migraine patients, its mechanism of action, and a summary of the most important US clinical data for this migraine treatment.

1. Whitcup SM et al. Ann NY Acad Sci 2014;1329:67-80. 2. Gazerani P et al. Pain 2009;141:60-69. 3. Aoki KR. Headache 2003;43:S9-15. 4. Jeynes LC et al. Pain Practice 2008;8:269-276. 5. Cui M et al. Pain 2004;107:125-133. 6. Gazerani P et al. Pain 2006;122:315-325. 7. Aurora SK et al. Headache 2011;51:1358-1373. 8. Blumenfeld A et al. J Headache Pain 2018;19:13. 9. Dodick DW et al. Cephalalgia 2019;39:945-956.